1. Home
  2. MMLP vs ENTA Comparison

MMLP vs ENTA Comparison

Compare MMLP & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMLP
  • ENTA
  • Stock Information
  • Founded
  • MMLP 2002
  • ENTA 1995
  • Country
  • MMLP United States
  • ENTA United States
  • Employees
  • MMLP N/A
  • ENTA N/A
  • Industry
  • MMLP Oil Refining/Marketing
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMLP Energy
  • ENTA Health Care
  • Exchange
  • MMLP Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • MMLP 139.6M
  • ENTA 154.0M
  • IPO Year
  • MMLP 2002
  • ENTA 2013
  • Fundamental
  • Price
  • MMLP $3.60
  • ENTA $5.59
  • Analyst Decision
  • MMLP
  • ENTA Buy
  • Analyst Count
  • MMLP 0
  • ENTA 4
  • Target Price
  • MMLP N/A
  • ENTA $17.25
  • AVG Volume (30 Days)
  • MMLP 117.0K
  • ENTA 228.9K
  • Earning Date
  • MMLP 04-16-2025
  • ENTA 05-05-2025
  • Dividend Yield
  • MMLP 0.57%
  • ENTA N/A
  • EPS Growth
  • MMLP N/A
  • ENTA N/A
  • EPS
  • MMLP N/A
  • ENTA N/A
  • Revenue
  • MMLP $707,622,000.00
  • ENTA $66,590,999.00
  • Revenue This Year
  • MMLP $4.19
  • ENTA N/A
  • Revenue Next Year
  • MMLP N/A
  • ENTA N/A
  • P/E Ratio
  • MMLP N/A
  • ENTA N/A
  • Revenue Growth
  • MMLP N/A
  • ENTA N/A
  • 52 Week Low
  • MMLP $2.36
  • ENTA $4.71
  • 52 Week High
  • MMLP $4.13
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • MMLP 45.38
  • ENTA 31.66
  • Support Level
  • MMLP $3.44
  • ENTA $5.65
  • Resistance Level
  • MMLP $3.74
  • ENTA $5.96
  • Average True Range (ATR)
  • MMLP 0.19
  • ENTA 0.36
  • MACD
  • MMLP -0.02
  • ENTA -0.15
  • Stochastic Oscillator
  • MMLP 34.78
  • ENTA 4.77

About MMLP Martin Midstream Partners L.P. Limited Partnership

Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: